Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 6c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• CBRE Global Real Estate Income Fund adjusts September distribution after split
• Canaan Inc. (CAN) PT Lowered to $2 at BTIG